Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 04, 2022
Medidata, a Dassault Systèmes company, announced that Parexel is extending their 15-year global strategic partnership. This builds upon the trusted relationship between the two companies and sets the goal of jointly pioneering a new era of ...
read more
Wednesday, February 09, 2022
Novasep, a supplier of services and technologies for the life sciences industry, and Sartorius Stedim Biotech, a subgroup of the life science company Sartorius, announced the completion as of February 7, 2022, of the sale of Novasep’s chromatography ...
read more
Wednesday, February 09, 2022
AGC Biologics announced an expanded partnership to supply more plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19 vaccine at the company’s Heidelberg facility.
According to a recent news release from Pfizer and BioNTech, the ...
read more
Wednesday, February 09, 2022
Thermo Fisher Scientific has announced a multiyear partnership with Medidata Acorn AI, a Dassault Systèmes company. Through this partnership, the PPD clinical research business of Thermo Fisher has collaborated with Medidata to develop PPD TrueCast, ...
read more
Wednesday, February 09, 2022
Humanigen, Inc. and Cenexi, a French CDMO, announced a collaboration aimed at making Cenexi a preferred supplier of lenzilumab in France and the European Union. The initial step of the collaboration includes the execution of a Master Supply Agreement...
read more
Tuesday, February 08, 2022
Piramal Pharma Limited's Pharma Solutions business announced the expansion of its Antibody-Drug Conjugate (ADC) capabilities at the Grangemouth facility in Scotland and the investment in new Active Pharmaceutical Ingredient (API) infrastructure at ...
read more
Wednesday, February 09, 2022
PharmaLex Group has announced a merger agreement with Ascent Development Services.
Founded in 2017, Ascent’s team of experts work with emerging biopharma companies to understand and overcome differences in medical practice, culture and language in ...
read more
Wednesday, February 09, 2022
We have been made aware of a recent U.S. Commerce Department announcement that two WuXi Biologics (Cayman) subsidiaries in Shanghai and Wuxi will be added to the department's "Unverified List" (UVL) on February 8, 2022.
read more
Wednesday, February 09, 2022
Berkshire Sterile Manufacturing (BSM) has added formulation, lyophilization, and method development capabilities to complement their clients’ drug productions.
read more
Tuesday, February 15, 2022
Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, designed to seamlessly transition therapies from clinic to commercial launch for patients across the U.S. ...
read more
Tuesday, February 15, 2022
National Resilience, Inc. announced a manufacturing services agreement with Takeda’s Plasma-Derived Therapies Business Unit. As part of the agreement, Resilience will focus on supporting the development and manufacture of multiple products in Takeda’...
read more
Tuesday, February 15, 2022
ANGUS Chemical Company, a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets, today announced the expansion of its Sterlington, Louisiana manufacturing facility to include commercial production of...
read more
Monday, February 14, 2022
ProBioGen has announced a multi-product commercial license agreement with AstraZeneca to use the GlymaxX technology. Following evaluation of the technology under a research license, AstraZeneca will now continue to use GlymaxX and will integrate the ...
read more
Monday, February 14, 2022
mdgroup, a leading global medtech and patient health services company pioneering a patient-first approach to clinical research, has been named as one of the UK's fastest-scaling businesses in 2021's Organic Growth 25 (OG25) index in recognition of ...
read more
Friday, February 11, 2022
CytoReason has established itself as a global leader in computational modeling of human diseases. The company's multidisciplinary team of 65 leading biologists, bioinformaticians and data engineers has developed a technology that enables pharma and ...
read more